Potential effect modification of RTS,S/AS01 malaria vaccine efficacy by household socio-economic status

Stephaney Gyaase, Kwaku Poku Asante, Elisha Adeniji, Owusu Boahen, Matthew Cairns, Seth Owusu-Agyei, Stephaney Gyaase, Kwaku Poku Asante, Elisha Adeniji, Owusu Boahen, Matthew Cairns, Seth Owusu-Agyei

Abstract

Background: In the phase III RTS,S /AS01 trial, significant heterogeneity in efficacy of the vaccine across study sites was seen. Question on whether variations in socio - economic status (SES) of participant contributed to the heterogeinity of the vaccine efficacy (VE) remains unknown.

Methods: Data from the Phase III RTS,S /AS01 trial in children aged 5-17 months in Kintampo were re-analysed. SES of each child was derived from the Kintampo Health and Demographic Surveillance System, using principal component analysis of household assets. Extended Cox regression was used to estimate the interaction between RTS,S/AS01 VE and household SES.

Results: Protective efficacy of the RTS,S/AS0 vaccine significantly varied by participant's household SES, thus increase in household SES was associated with an increase in protective efficacy (P-value = 0.0041). Effect modification persisted after adjusting for age at first vaccination, gender, distance from community to the health facility, child's haemoglobin level, household size, place of residence and mothers' educational level.

Conclusion: Household SES may be a proxy for malaria transmission intensity. The study showed a significant modification of the RTS,S/AS01 malaria vaccine efficacy by the different levels of child's household socio - economic status.

Trial registration: Efficacy of GSK Biologicals' candidate malaria vaccine (25049) against malaria disease in infants and children in Africa. NCT00866619 prospectively registered on 20 March 2009.

Keywords: Malaria; Malaria incidence; Protective efficacy; Socio-economic status; Vaccine.

Conflict of interest statement

All authors declare no competing interest.

Figures

Fig. 1
Fig. 1
Description of distance/km travelled by paticipants from the community to the nearest health facility in the study area
Fig. 2
Fig. 2
Cumulative hazard of the effect of child’s HH SES on the RTS,S /AS01 malaria vaccine efficacy over the follow-up period

References

    1. National Malaria Control Programme . 2017 Annual Report. Accra: Ghana Health Service; 2017.
    1. World Health Organization . World Malaria Report 2019. 2019.
    1. Olotu A, Fegan G, Wambua J, Nyangweso G, Awuondo KO, Leach A, et al. Four-year efficacy of RTS, S/AS01E and its interaction with malaria exposure. N Engl J Med. 2013;368(12):1111–1120. doi: 10.1056/NEJMoa1207564.
    1. RTS SCTP Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS Med. 2014;11(7):e1001685. doi: 10.1371/journal.pmed.1001685.
    1. Gosselin V, Généreux M, Gagneur A, Petit G. Effectiveness of rotavirus vaccine in preventing severe gastroenteritis in young children according to socioeconomic status. Hum Vaccin Immunother. 2016;12(10):2572–2579. doi: 10.1080/21645515.2016.1189038.
    1. Lopman BA, Pitzer VE, Sarkar R, Gladstone B, Patel M, Glasser J, et al. Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS One. 2012;7(8):e41720. doi: 10.1371/journal.pone.0041720.
    1. Hammer R, Capili C, Wi C-I, Ryu E, Rand-Weaver J, Juhn YJ. A new socioeconomic status measure for vaccine research in children using individual housing data: a population-based case-control study. BMC Public Health. 2016;16(1):1000. doi: 10.1186/s12889-016-3673-x.
    1. Owusu-Agyei S, Ansong D, Asante K, Owusu SK, Owusu R, Brobby NAW, et al. Randomized controlled trial of RTS, S/AS02D and RTS, S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children. PLoS One. 2009;4(10):e7302. doi: 10.1371/journal.pone.0007302.
    1. Asante KP, Owusu-Agyei S, Cairns M, Dodoo D, Boamah EA, Gyasi R, et al. Placental malaria and the risk of malaria in infants in a high malaria transmission area in Ghana: a prospective cohort study. J Infect Dis. 2013;208(9):1504–1513. doi: 10.1093/infdis/jit366.
    1. Rts S. Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015;386(9988):31–45. doi: 10.1016/S0140-6736(15)60721-8.
    1. Leach A, Vekemans J, Lievens M, Ofori-Anyinam O, Cahill C, Owusu-Agyei S, et al. Design of a phase III multicenter trial to evaluate the efficacy of the RTS, S/AS01 malaria vaccine in children across diverse transmission settings in Africa. Malar J. 2011;10(1):224. doi: 10.1186/1475-2875-10-224.
    1. Vyas S, Kumaranayake L. Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plan. 2006;21(6):459–468. doi: 10.1093/heapol/czl029.
    1. Andersen PK, Gill RD. Cox’s regression model for counting processes: a large sample study. Ann Stat. 1982;10(4):1100–20. doi: 10.1214/aos/1176345976.
    1. Xu Y, Cheung Y, Lam K, Tan S, Milligan P. A simple approach to the estimation of incidence rate difference. Am J Epidemiol. 2010;172(3):334–343. doi: 10.1093/aje/kwq099.
    1. Kelly C, Arnold R, Galloway Y, O'Hallahan J. A prospective study of the effectiveness of the New Zealand meningococcal B vaccine. Am J Epidemiol. 2007;166(7):817–823. doi: 10.1093/aje/kwm147.
    1. Bbaale E, Okumu IM. Socio-economic status and malaria prevalence among infants: the case of Uganda. Afr J Econ Rev. 2016;4(1):132–142.
    1. Tusting LS, Bottomley C, Gibson H, Kleinschmidt I, Tatem AJ, Lindsay SW, et al. Housing improvements and malaria risk in sub-Saharan Africa: a multi-country analysis of survey data. PLoS Med. 2017;14(2):1–15. doi: 10.1371/journal.pmed.1002234.
    1. Tusting LS, Ippolito MM, Willey BA, Kleinschmidt I, Dorsey G, Gosling RD, et al. The evidence for improving housing to reduce malaria: a systematic review and meta-analysis. Malar J. 2015;14(1):209. doi: 10.1186/s12936-015-0724-1.
    1. Krefis AC, Schwarz NG, Nkrumah B, Acquah S, Loag W, Sarpong N, et al. Principal component analysis of socioeconomic factors and their association with malaria in children from the Ashanti region, Ghana. Malar J. 2010;9(1):201. doi: 10.1186/1475-2875-9-201.
    1. Savy M, Edmond K, Fine PE, Hall A, Hennig BJ, Moore SE, et al. Landscape analysis of interactions between nutrition and vaccine responses in children. J Nutr. 2009;139(11):2154S–2218S. doi: 10.3945/jn.109.105312.
    1. Velasquez DE, Parashar U, Jiang B. Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors. Expert Rev Vaccines. 2018;17(2):145–161.
    1. Drakeley C, Corran P, Coleman P, Tongren J, McDonald S, Carneiro I, et al. Estimating medium-and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci. 2005;102(14):5108–5113. doi: 10.1073/pnas.0408725102.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir